Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemiaOussama ElMokh, Michel A. Duchosal, Saki Matsumoto et al.|Cell Death and Disease|2022Cited by 16
The Human Exersome Initiative (HEI): Rationale, study design, and protocolDaria Neyroud, Aaron L. Baggish, Héctor Gallart‐Ayala et al.|PLoS ONE|2025Cited by 0